4th Bacteriophage Therapy Summit
Evvnt Promotion / evvnt
Archiv
14.02.2022 - 16.02.2022 Online
Time: 09:00 to 17:00
Kongressthemen
With increasing regulatory flexibility for phage-based applications, address critical questions to help your phage technologies advance through commercial development. Are you ready to gain the insights needed to radically transform your bacteriophage therapies into commercially viable products?
With increasing regulatory flexibility for phage-based applications, address critical questions to help your phage technologies advance through commercial development. Are you ready to gain the insights needed to radically transform your bacteriophage therapies into commercially viable products?
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/923318-3?pid=4832
Speakers: Bob Blasdel, Research Director, Vesale Pharma , Cara Fiore, Microbiologist, FDA Office of Vaccines Research and Review , and more.
Brochure: https://go.evvnt.com/923318-3?pid=4832
Speakers: Bob Blasdel, Research Director, Vesale Pharma , Cara Fiore, Microbiologist, FDA Office of Vaccines Research and Review , and more.
Anfragen und Anmeldung:
https://go.evvnt.com/923318-2?pid=4832
Herr Customer Service
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
